Wang, J., Zhang, Q., Sun, T., Li, H., Cheng, Y., Tong, Z., . . . Xu, B. An open‐label, single‐arm, multicenter, phase II trial of bireociclib as monotherapy for heavily pretreated HR‐positive, HER2‐negative advanced breast cancer patients: BRIGHT‐1 trial. Wiley.
Chicago Style (17th ed.) CitationWang, Jiayu, et al. An Open‐label, Single‐arm, Multicenter, Phase II Trial of Bireociclib as Monotherapy for Heavily Pretreated HR‐positive, HER2‐negative Advanced Breast Cancer Patients: BRIGHT‐1 Trial. Wiley.
MLA (9th ed.) CitationWang, Jiayu, et al. An Open‐label, Single‐arm, Multicenter, Phase II Trial of Bireociclib as Monotherapy for Heavily Pretreated HR‐positive, HER2‐negative Advanced Breast Cancer Patients: BRIGHT‐1 Trial. Wiley.
Warning: These citations may not always be 100% accurate.